It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
There’s life in the old dog yet: Infringement under the doctrine of equivalence
-
Unified Patent Court will open doors early 2023
-
EPO: T 1756/11, European Patent Office (EPO), Board of Appeal, 14 January 2015
-
UK Government guidance on Unitary Patent system in case there is no Brexit deal
-
Barcelona Patent Court judgment on claims comprising technical and non-technical features
-
Third Civil Division for patent infringement cases in Duesseldorf
-
CJEU’s Advocate General in Abraxis (C-443/17) denies SPCs for new formulations of old drugs and questions Neurim approach
-
‘Renewal fees of the unitary patent are not meant to sustain national patent offices’
-
Give me the money
-
Patent case: Actavis UK Limited v Eli Lilly, United Kingdom